Assignee
SALUBRIS BIOTHERAPEUTICS INC
US·2 granted patents·3 pending applications·1 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0171US11046741B2Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·1 cites·38 claims
- 0267US2023322877A1Human neuregulin-1 (nrg-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0364US11718652B2Human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereofSALUBRIS BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 8, 2023·0 cites·35 claims
- 0453US2025228917A1Methods of treating fibrosis and arrhythmia with a neuregulin-1 fusion proteinSALUBRIS BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0552US2024254184A1Il-15 fusion proteins and methods of making and using the sameSALUBRIS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →